CK Life Sciences International (Holdings), Inc. (HK:0775) has released an update.
CK Life Sciences Int’l., (Holdings) Inc. warns shareholders and potential investors of an expected significant decline in profits for the first half of 2024 compared to the same period in 2023, primarily due to escalating finance costs. While the company’s nutraceutical business has remained stable, its agriculture-related ventures faced challenges. Investors are urged to exercise caution and look out for the detailed interim results due to be released on August 13, 2024.
For further insights into HK:0775 stock, check out TipRanks’ Stock Analysis page.
